In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13186
Abstract: Aims Canagliflozin is a recently approved drug for use in the treatment of type 2 diabetes. The potential for canagliflozin to cause clinical drug–drug interactions (DDIs) was assessed. Methods DDI potential of canagliflozin was investigated… read more here.
Keywords: mgr mol; drug; potential canagliflozin; interaction ... See more keywords